Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Spring Bank Ph CS (SBPH)

Spring Bank Ph CS (SBPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,893
  • Shares Outstanding, K 17,267
  • Annual Sales, $ 0 K
  • Annual Income, $ -24,100 K
  • 60-Month Beta 1.13
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.14
Trade SBPH with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.32
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/26/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.25
  • Number of Estimates 1
  • High Estimate -0.25
  • Low Estimate -0.25
  • Prior Year -0.42
  • Growth Rate Est. (year over year) +40.48%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9710 +24.61%
on 10/30/20
1.5400 -21.43%
on 11/12/20
-0.0400 (-3.20%)
since 10/20/20
3-Month
0.9710 +24.61%
on 10/30/20
1.5500 -21.94%
on 09/03/20
-0.2100 (-14.79%)
since 08/20/20
52-Week
0.8000 +51.25%
on 03/16/20
4.8000 -74.79%
on 12/02/19
-1.9900 (-62.19%)
since 11/20/19

Most Recent Stories

More News
Spring Bank Pharmaceuticals Stockholders Approve Combination with F-star Therapeutics

1-for-4 Reverse Stock Split to be Effective November 20, 2020

SBPH : 4.8400 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers; Investors are Encouraged to Contact the Firm – MVC, WPX, PTI, SBPH

NEW YORK, Nov. 07, 2020 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:

MVC : 9.12 (+2.59%)
WPX : 9.43 (+5.36%)
SBPH : 4.8400 (unch)
PTI : 1.1100 (-3.48%)
Spring Bank Pharmaceuticals Announces Special Dividend of Contingent Value Rights

HOPKINTON, Mass., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH) (“Spring Bank”), a clinical-stage biopharmaceutical company developing novel therapeutics for...

SBPH : 4.8400 (unch)
Spring Bank Announces Poster Presentation at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting

HOPKINTON, Mass., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology and inflammatory...

SBPH : 4.8400 (unch)
Spring Bank Class Action: Halper Sadeh LLP Announces Filing of Shareholder Class Action Lawsuit Against Spring Bank Pharmaceuticals, Inc.; Investors Are Encouraged to Contact the Firm - SBPH

Halper Sadeh LLP, a global investor rights law firm, announces the filing of a shareholder class action lawsuit against Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH) in connection with its merger with...

SBPH : 4.8400 (unch)
Rigrodsky & Long, P.A. Files Class Action Suit Against Spring Bank Pharmaceuticals, Inc.

WILMINGTON, Del., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of Delaware on...

SBPH : 4.8400 (unch)
IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Is Investigating the Following Companies; Shareholders are Encouraged to Contact the Firm – SBPH, GLIBA, CBMG, PTI

NEW YORK, NY / ACCESSWIRE / September 23, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH) concerning potential violations...

SBPH : 4.8400 (unch)
GLIBA : 91.73 (-2.57%)
CBMG : 19.75 (unch)
PTI : 1.1100 (-3.48%)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of SBPH, NTN, PTI and GLIBA Mergers

WILMINGTON, Del., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:

SBPH : 4.8400 (unch)
NTN : 5.40 (+1.12%)
PTI : 1.1100 (-3.48%)
GLIBA : 91.73 (-2.57%)
Moore Kuehn Encourages SBPH, PFNX, VAR, and PRNB Investors to Contact Law Firm

NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether...

SBPH : 4.8400 (unch)
VAR : 177.07 (-0.02%)
PRNB : 100.05 (+0.10%)
PFNX : 12.75 (-0.08%)
Lifshitz Law Firm, P.C. Announces Investigation of Otelco Inc. (NASDAQ: OTEL), Pfenex Inc. (NYSE: PFNX), Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH), and Varian Medical Systems, Inc. (NYSE: VAR)

NEW YORK, Sept. 01, 2020 (GLOBE NEWSWIRE) --

OTEL : 11.74 (+0.15%)
PFNX : 12.75 (-0.08%)
SBPH : 4.8400 (unch)
VAR : 177.07 (-0.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

Spring Bank Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of therapeutics using its proprietary small molecule nucleic acid hybrid chemistry platform. The company is developing SB 9200, for the treatment of viral diseases, including...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 1.3764
1st Resistance Point 1.2932
Last Price 4.8400
1st Support Level 1.1384
2nd Support Level 1.0668
3rd Support Level N/A

See More

Last Price 4.8400
52-Week High 4.8000
Fibonacci 61.8% 3.2720
Fibonacci 50% 2.8000
Fibonacci 38.2% 2.3280
52-Week Low 0.8000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar